VIVANZA BIOSCIENCES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.13 INR | +1.25% |
|
-3.21% | -24.51% |
| Sales 2022 | 112M 1.34M | Sales 2023 | 182M 2.18M | Capitalization | 752M 9.02M |
|---|---|---|---|---|---|
| Net income 2022 | 3M 35.98K | Net income 2023 | 5M 59.97K | EV / Sales 2022 | 7.22 x |
| Net Debt 2022 | 54.52M 654K | Net Debt 2023 | 78.27M 939K | EV / Sales 2023 | 4.57 x |
| P/E ratio 2022 |
227
x | P/E ratio 2023 |
126
x | Employees | 5 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 39.98% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.25% | ||
| 1 week | -3.21% | ||
| Current month | +19.73% | ||
| 1 month | +28.23% | ||
| 3 months | +1.12% | ||
| 6 months | -23.66% | ||
| Current year | -24.51% |
1 week
8.00
8.60
1 month
6.179.54
Current year
5.7011.72
1 year
5.7016.13
3 years
5.7021.00
5 years
1.2521.00
10 years
0.4321.00
| Managers | Title | Age | Since |
|---|---|---|---|
Jaynedra Mehta
CEO | Chief Executive Officer | - | 25/23/25 |
| Director of Finance/CFO | - | 17/16/17 | |
Avinash Bhojwani
CMP | Compliance Officer | - | 27/22/27 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 29/19/29 | |
Sunil Shah
BRD | Director/Board Member | 43 | 06/20/06 |
Apeksha Vyas
BRD | Director/Board Member | - | 25/23/25 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/24/26 | 8.13 | +1.25% | 192,345 |
| 25/24/25 | 8.03 | -1.47% | 229,301 |
| 24/24/24 | 8.15 | -1.45% | 239,961 |
| 23/24/23 | 8.27 | -0.60% | 211,434 |
| 22/24/22 | 8.32 | -0.95% | 234,446 |
Delayed Quote Bombay S.E., April 26, 2024 at 03:30 pm IST
More quotes
Vivanza Biosciences Limited is an India-based specialty pharmaceutical company. The Company offers pharmaceutical products and pharma products. The Company is focused on commercializing generic pharmaceuticals, offering patients accessible medicines. The Company operates in only one that is trading of pharmaceutical product. Its products include gloves and surgical. Gloves products include latex examination gloves powdered, latex surgical powdered, latex free examination gloves-vinyl, latex free examination gloves-nitrile and Latex examination gloves-powdered. The Companyâs products catalogues include Injectable Products, Vivanza Gloves and Therapeutic Index Injection. The Company offers gloves and surgical products to the industries include chemical, energy, industry, manufacturing and materials.
Sector
Pharmaceuticals
Calendar
29/05/2024
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -24.51% | 3.9M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- VIVANZA6 Stock
